Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

NCT04552288 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor
Solid Carcinoma
Solid Tumor, Adult
Hematologic Malignancy

Interventions

DRUG: Benralizumab

Sponsor

Memorial Sloan Kettering Cancer Center